Status:
COMPLETED
Prevalence of Multidrug Resistant Micro-organism Carriage in Patients Undergoing an ERCP in Four Different Countries
Lead Sponsor:
Marco J. Bruno
Collaborating Sponsors:
Boston Scientific Corporation
Conditions:
Drug Resistance, Multiple, Bacterial
Cholangiopancreatography, Endoscopic Retrograde
Eligibility:
All Genders
18+ years
Brief Summary
The duodenoscopes currently used for Endoscopic Retrograde Cholangio - and Pancreaticography (ERCP) examinations are reusable and are therefore washed and disinfected after each use. Despite this, the...
Eligibility Criteria
Inclusion
- The subject is planned to undergo an ERCP procedure, either through an outpatient department or an inpatient department
- The subject is capable to understand the information required to give informed consent
Exclusion
- In case the inclusion criteria were not met
Key Trial Info
Start Date :
January 31 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 30 2024
Estimated Enrollment :
1244 Patients enrolled
Trial Details
Trial ID
NCT05303662
Start Date
January 31 2022
End Date
December 30 2024
Last Update
August 8 2025
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
UPMC
Pittsburgh, Pennsylvania, United States, 15213
2
AIG hospitals
Hyderabad, Telangana, India, 500032
3
Humanitas research hospital
Milan, Lombardy, Italy, 20089
4
Erasmus MC
Rotterdam, South Holland, Netherlands, 3015GD